Quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease

被引：0
|
作者：
Revicki, D
Sorensen, S
Maton, PN
Orlando, R
机构：
[1] MEDTAP INT, BETHESDA, MD USA
[2] TULANE SCH MED, NEW ORLEANS, LA USA
[3] OKLAHOMA FDN DIGEST RES, OKLAHOMA CITY, OK USA
来源：
GASTROENTEROLOGY | 1997年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A268 / A268
页数：1
相关论文
共 50 条
  • [1] Quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease
    Sorensen, S
    Revicki, D
    Maton, P
    Orlando, R
    QUALITY OF LIFE RESEARCH, 1997, 6 (7-8) : 369 - 369
  • [2] Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease
    Revicki, DA
    Sorensen, S
    Maton, PN
    Orlando, RC
    DIGESTIVE DISEASES, 1998, 16 (05) : 284 - 291
  • [3] Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease
    Richter, JE
    Sabesin, SM
    Kogut, DG
    Kerr, RM
    Wruble, LD
    Collen, MJ
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (09): : 1766 - 1772
  • [4] Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease - a prospective, controlled trial
    Maton, PN
    Orlando, R
    Joelsson, B
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (06) : 819 - 826
  • [5] Symptom resolution in poorly responsive gastroesophageal reflux disease (GERD): Superiority of omeprazole over ranitidine
    Maton, PN
    Orlando, R
    Joelsson, B
    GASTROENTEROLOGY, 1997, 112 (04) : A213 - A213
  • [6] RANITIDINE IN THE TREATMENT OF SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE
    SHERBANIUK, R
    WENSEL, R
    BAILEY, R
    TRAUTMAN, A
    GRACE, M
    KIRDEIKIS, P
    JEWELL, L
    PARE, P
    LEVESQUE, D
    FARLEY, A
    ARCHAMBAULT, A
    THOMSON, ABR
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1984, 6 (01) : 9 - 15
  • [7] Symptomatic gastroesophageal reflux disease (GERD): Intermittent treatment (IT) with omeprazole (OM) and ranitidine (RAN) as a strategy for management
    Bardhan, KD
    MullerLissner, S
    Bigard, MA
    Porro, GB
    Ponce, J
    Hosie, J
    Scott, M
    Weir, DG
    Gillon, K
    Peacock, R
    Fulton, C
    GUT, 1997, 41 : A203 - A203
  • [8] OMEPRAZOLE VERSUS VERY HIGH-DOSES OF RANITIDINE IN CHILDREN WITH REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE
    CUCCHIARA, S
    MINELLA, R
    FRANCESCHI, M
    IERVOLINO, C
    FRANCO, MT
    EMILIANO, M
    SCOPPA, A
    GASTROENTEROLOGY, 1993, 104 (04) : A59 - A59
  • [9] Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease
    van Zyl, J
    van Rensburg, C
    Vieweg, W
    Fischer, R
    DIGESTION, 2004, 70 (01) : 61 - 69
  • [10] Symptomatic gastroesophageal reflux disease (GERD): Intermittent treatment (IT) with omeprazole (OM) and ranitidine (RAN) as a strategy for management.
    Bardhan, KD
    MullerLissner, S
    Bigard, MA
    Porro, GB
    Ponce, J
    Hosie, J
    Scott, M
    Weir, DG
    Gillon, K
    Peacock, R
    Fulton, C
    GASTROENTEROLOGY, 1997, 112 (04) : A65 - A65
12345